FDA – Page 5 – Policy & Medicine

Letters from Grassley: FDA to Clarify Policies on Medical Devices

Five Part Podcast Series on FDA Features John Kamp of Coalition for Healthcare Communication

FDA Official Cleared of Conflict Allegations in Heparin Contamination Case

Three Felonies a Day: How the Feds Target the Innocent

GAO to FDA: Action Needed to Improve Timeliness on Clinical Investigator Oversight

FDA Announces Strategic Plan for Risk Communication

FDA Hires IOM to Review Medical Device Approval System

Letters from Grassley: Are Statins Safe? Is the Sky Blue?

JAMA: HPV and Cervical Cancer Treatment Gardasil – Choosing to Ignore the Facts